Acceleron Pharma Inc Stock Price (XLRN)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

The Principal Healthcare ETF Thriving under Vaccine ProgressThu, 22 Oct 2020 09:49:32 UTC via ETF Trends
Tenet Healthcare Corp's (THC) CEO Ron Rittenmeyer on Q3 2020 Results - Earnings Call TranscriptWed, 21 Oct 2020 17:46:03 UTC via Seeking Alpha
OxyContin maker Purdue Pharma agrees to plead guilty to three criminal chargesWed, 21 Oct 2020 10:55:05 UTC via MSNBC
Tenet Healthcare Corporation 2020 Q3 - Results - Earnings Call PresentationTue, 20 Oct 2020 16:34:37 UTC via Seeking Alpha
Vifor Pharma (GNHAF) Investor Presentation - SlideshowMon, 19 Oct 2020 14:56:59 UTC via Seeking Alpha
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer ConferenceSun, 18 Oct 2020 12:50:09 UTC via Yahoo Finance
Allscripts Healthcare Solutions: Hidden ValueThu, 15 Oct 2020 06:35:20 UTC via Seeking Alpha
Merck: You Should Own A Stake In This Pharma CompanyTue, 13 Oct 2020 12:00:20 UTC via Seeking Alpha
Antares Pharma Inc (ATRS): Hedge Funds In Wait-and-See ModeMon, 12 Oct 2020 18:28:29 UTC via Yahoo Finance
Sharps Compliance's Attractive Position In Healthcare Waste ManagementMon, 12 Oct 2020 11:19:48 UTC via Seeking Alpha

Acceleron Pharma Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:XLRN

You don't have any alerts set for IEX:XLRN.

About Acceleron Pharma Inc

Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair.

CEOHabib J. Dable IndustryBiotechnology SectorHealthcare Websitehttp://www.acceleronpharma.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time XLRN to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.